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 2016 by The North American Menopause SocietyLETTERS TO THE EDITORTo the Editor: 2. Chen Z, Foster MW, Zhang J, et al. An essential role for mitochondrial
aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl AcadThe pathophysiology of menopause related vasomotor
symptoms remains an enigma. Recently, authors have hypoth-
esized about the effect of endogenous peripheral nitric oxide
(NO) and these symptoms.
Alison J. Huang et al1 postulate that continuous use of
nitroglycerin rapidly leads to tolerance to the drug’s vaso-
dilatory effects and cross-tolerance to endogenous nitrates,
as a result of enhanced NO degradation.2-7 Although
this tolerance limits the usefulness of nitroglycerin for
chest pain, it offers a potentially innovative approach to
treating hot flashes, because women who develop cross-
tolerance should experience a marked reduction in hot
flashes as a result of suppression of NO-mediated peripheral
vasodilation.
On the other hand, Bailey et al,8 explain that exercise
training reduces thermoregulatory dysfunction via stabiliz-
ation of central thermoregulatory control, that is, lowering
core body temperature and improving heat dissipation
thresholds, alongside improvements in peripheral mechan-
isms that allow for greater heat dissipation (sweating sensi-
tivity). These adaptations likely include increases in the
number of sweat expulsions per minute, sweat gland hyper-
trophy, increased NO availability, and others.9 The reduction
in estrogen associated with menopause causes endothelial
dysfunction via decreased NO bioavailability10 and/or
increased reactive oxygen species scavenging NO.11 Exercise
increases endothelial NO synthase expression via similar
mechanisms of transcriptional regulation to that of estrogen12
and augments NO-mediated vasodilation.13
It appears that these hypotheses are in conflict. Further
discussion by the authors may clarify the existing knowledge
base regarding the role of nitric oxide and vasodilatation. This
information may aid menopause practitioners in educating
and caring for their patients.
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In Reply:
We thank Professor Steiner for her interest in our recent
publication and the opportunity to discuss the role of nitric
oxide (NO) inmenopausal hot flushmechanismsand treatment.
Initially, it is important to highlight that while the two studies
investigate the effects of ‘‘treatment’’ via different interventions
(exercise training1 and nitrogylcerin therapy2) to improve the
frequency and severity of self-reported hot flushes in postme-
nopausal women; both interventions alter NO availability. In
the following text, we have outlined how the two interventions
potentially impact hot flushes, potentially via NO pathways.
During a bout of exercise the endothelium releases NO in
response to episodic increases in blood flow, and subsequently
shear stress along the artery wall. NO diffuses into the smooth
muscle cells causing relaxation and artery vasodilation, which. Unauthorized reproduction of this article is prohibited.
Cis endothelium-dependent. Exercise training, as performed in to determine efficacy, ideally which include outcomes
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Menopause, Vol. 24, No. 1, 2017 119our study,1 causes regular, episodic increases in vascular shear
stress that causes NO release during each exercise session3 and
thus has been shown to improve both local3 and systemic4,5
NO-mediated endothelial function. Nitroglycerin is an NO
donor that causes increased systemic NO availability that acts
directly on smooth muscle cells causing endothelium-inde-
pendent vasodilation when administered acutely. Huang et al,2
administered a daily dose of nitroglycerin for 6 weeks and
inferred that cross-tolerance to organic nitrates occurred with
the continuous nitroglycerin administration that surpressed
NO-mediated vasodilation. Endothelial function, microvascu-
lar function (eg, cutaneous vasodilation) or other thermoreg-
ulatory variables (e.g. core body temperature) were not
measured by Huang,2 nor was the frequency and severity of
hot flushes prior to the onset of cross-tolerance where NO
availability would have been elevated.
There is evidence that acute alterations in NO have a role in
cutaneous vasodilation during an individual hot flush,6 but it
is currently unknownwhether NO is involved in the trigger for
hot flushes. Nevertheless, the self-report data from ours1 and
Huang’s2 studies suggest that both interventions reduce the
frequency of hot flushes, which may provide evidence that
NO availability is involved in the trigger for hot flushes;
the specific mechanism(s) are unclear however it is plausible
that NO impacts on the thermoregulatory system,7 the
sympathetic nervous system8 or neurotransmitters in the
brain9,10; all of which have been shown to be involved in
the hot flush trigger.
The self-report data from ours1 and Huang’s2 studies also
suggest that both interventions reduce the severity of hot
flushes. Physiological severity was not measured in the
Huang study, but we have direct evidence that exercise training
reduces the physiological severity of hot flushes by reducing
the amount of cutaneous vasodilation and sweating during a hot
flush.11 We suggest that this is due to more efficient thermo-
regulation, including endothelial dependent NO-mediated vas-
odilation.Huang infers that cross tolerance toNOwould reduce
cutaneous vasodilation during a hot flush.
There are a number of distinct differences between the two
interventions that are noteworthy. Exercise training enhances
endothelial function,1 which has been shown to be impaired in
postmenopausal women and especially in symptomatic
women,12 whereas chronic daily administration of nitrogly-
cerin can cause ‘‘cross tolerance’’ to organic nitrates and
possibly negate the requirement for endothelial dependent
vasodilation, both of which may lead to endothelial dysfunc-
tion, that might have implications for those with coronary
artery disease.13,14 Furthermore, exercise does not cause
headaches like nitroglycerin, and exercise training has
additional benefits to reducing hot flush frequency and
severity (eg, improved thermoregulation, neural activity15)
as well as several well-known multifaceted benefits for
improving health in postmenopausal women.16
It is also important to emphasize that both of these studies1,2
require confirmation with full randomized control trialsopyright @ 2016 The North American Menopause Society.measurements of both self-reported and physiologically
measured hot flushes that include cutaneous vasodilation,
sweating, and vascular function.11
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We agree that the pathophysiology of menopause-related
vasomotor symptoms remains frustratingly unclear. However,
our exploration of continuous nitroglycerin as a treatment
strategy for hot flashes is not predicated on any particular
hypothesis about the causal trigger for these symptoms.1 We
only assume that, once triggered, hot flashes manifest in the
form of cutaneous vasodilation that is likely mediated by
nitric oxide (NO) activation of vascular smooth muscle.2 If
this is true, then treatment strategies directed at dampening
NO-mediated vasodilation (such as induction of nitrate cross-
tolerance) may suppress the primary physical manifestations
of hot flashes, regardless of the original stimulus for these
symptoms.
We appreciate that menopause may be associated with
changes in vascular endothelial function that are in turn
associated with decreased NO bioavailability, and that a prior
study has suggested that changes in endothelial-dependent
flow-mediated dilation are associated with more severe vaso-
motor symptoms.3 However, evidence is lacking that these
changes are specifically responsible for development of men-
opausal vasomotor symptoms. Similar changes in flow-medi-
ated dilation have also been observed in other populations
such as aging men4 or cardiac patients using long-term oral
nitrates,5 and yet high rates of vasomotor symptoms are not
reported in these populations. Even if decreased endothelial
response to endogenous NO is associated with vasomotor
symptoms, it is unlikely that it is the primary cause of
these symptoms.
With regard to the exercise study by Bailey et al,6 larger-
scale randomized trials of exercise-based interventions have
unfortunately failed to demonstrate a reduction in vasomotorCopyright @ 2016 The North American Menopause Society
120 Menopause, Vol. 24, No. 1, 2017exercise is effective in reducing hot flashes, it does not
necessarily follow that this is mediated by exercise-induced
increase in NO availability.6 Regular exercise has a multitude
of effects—not just at the tissue-specific level, but also at the
level of the organ system and the individual woman and her
perception of vasomotor symptoms. Reported reductions in
hot flashes among women who exercise may (and probably
do) arise from other mechanisms.
Two things are certain—hot flashes involve vasodilation,
and NO is a vasodilator. If we go one step further and accept
laboratory-based evidence that NO is the primary vasodilator
implicated in hot flashes,2 then interventions that target NO-
mediated vasodilation may offer promise for treatment. Of
course, this does not lessen the need for a better understanding
of the upstream stimuli that give rise to these perplexing
symptoms in the first place.
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